Nadia Vazirpanah
Utrecht University(NL)University Medical Center Utrecht(NL)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Lymphatic System and Diseases, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Liver Disease Diagnosis and Treatment, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development(2015)427 cited
- → PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation(2018)121 cited
- → Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?(2017)95 cited
- → Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis(2018)82 cited
- → mTOR inhibition by metformin impacts monosodium urate crystal–induced inflammation and cell death in gout: a prelude to a new add-on therapy?(2019)67 cited
- → Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting(2019)66 cited
- → Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome(2019)61 cited
- → CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis(2020)46 cited
- → Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients(2020)36 cited
- → Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout(2017)21 cited